Ponatinib treatment in chronic myeloid leukemia cell lines targets aurora kinase A/FOXM1 axis-Reference-Cited by-同舟云学术

Ponatinib treatment in chronic myeloid leukemia cell lines targets aurora kinase A/FOXM1 axis

Published:2020-01-28 Issue:2 Volume:38 Page:201-203
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Mancini Manuela¹^ORCID,De Santis Sara¹,Monaldi Cecilia¹,Bavaro Luana¹,Martelli Margherita¹,Gugliotta Gabriele¹,Castagnetti Fausto¹,Rosti Gianantonio¹,Santucci Maria Alessandra¹,Martinelli Giovanni²,Cavo Michele¹,Soverini Simona¹

Affiliation:

1. Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale—DIMES—Istituto di Ematologia “L. e A. Seràgnoli” University of Bologna Bologna Italy

2. Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) Srl Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Meldola Italy

Funder

Ministry of Health

Associazione Italiana Contro le Leucemie-Linfomi e Mieloma

Associazione Italiana per la Ricerca sul Cancro

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.2703

Reference10 articles.

1. Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia

2. AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the T315I Mutant and Overcomes Mutation-Based Resistance

3. Hyper-activation of Aurora kinase a-polo-like kinase 1-FOXM1 axis promotes chronic myeloid leukemia resistance to tyrosine kinase inhibitors

4. Gadd45 Proteins: Key Players of Repair-Mediated DNA Demethylation

5. Polo-like Kinase 1 (Plk1) as a Novel Drug Target in Chronic Myeloid Leukemia: Overriding Imatinib Resistance with the Plk1 Inhibitor BI 2536

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overcoming Resistance to Kinase Inhibitors: The Paradigm of Chronic Myeloid Leukemia;OncoTargets and Therapy;2022-01

2. Current Views on the Interplay between Tyrosine Kinases and Phosphatases in Chronic Myeloid Leukemia;Cancers;2021-05-12